Clinical Trial

Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy

Completed
View on ClinicalTrials.gov →
Summary
The current study is a multiple-arm, single blinded, and controlled randomized trial. It will be conducted in two gynecological endoscopy centers: • ElShatby University Hospital, a tertiary level hospital in Alexandria, Egypt. • Al-Madina Women Hospital, A specialized hospital of Obstetrics and Gynecology, Alexandria, Egypt. Patient selection: women with uterine leiomyomata and planning for laparoscopic myomectomy will be assessed for eligibility then will be enrolled in the trial according to the following inclusion and exclusion criteria, after providing a written informed consent of participation. Outcome variables of the study: The primary outcome is intraoperative blood loss and the change in postoperative hemoglobin. The secondary outcomes of this study are the operative time of performing uterine arteries occlusion and the postoperative ovarian reserve.
Protocol Amendment History 1 change
critical Trial completed 2026-07-15
Trial Details
NCT Number NCT07352761
Lead Sponsor Alexandria University
Conditions Uterine Fibroids (Leiomyoma), Myomectomy, Myomectomy; Surgical Blood Loss
Enrollment 60 participants
Start Date 2025-05-01
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-02-25 (estimated)
Updated on ClinicalTrials.gov 2026-07-14